Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
10x GenomicsTXG | Open-market sale10b5-1 plan | 09/22 | 09/24 | 5,723 sh5 trades | $81.19avg. | $464,667.85 | −19.4% | |
10x GenomicsTXG | Open-market sale10b5-1 plan | 09/22 | 09/24 | 25,000 sh5 trades | $81.22avg. | $2,030,561.55 | −2.3% | |
10x GenomicsTXG | Open-market sale10b5-1 plan | 06/22 | 06/24 | 30,000 sh4 trades | $34.44avg. | $1,033,294.79 | −2.6% | |
10x GenomicsTXG | Open-market sale10b5-1 plan | 06/16 | 06/18 | 5,723 sh2 trades | $32.63avg. | $186,760.09 | −15.3% | |
10x GenomicsTXG | Open-market sale10b5-1 plan | 05/22–05/26 | 05/27 | 28,893 sh2 trades | $24.54avg. | $709,038.78 | −2.5% | |
Hindson Benjamin J.SEE REMARKS | 10x GenomicsTXG | Open-market sale | 05/22 | 05/27 | 11,595 sh | $24.44 | $283,381.8 | −2.3% |
Adam TaichCFO | 10x GenomicsTXG | Open-market sale | 05/22 | 05/27 | 15,098 sh | $24.44 | $368,995.12 | −3.8% |
10x GenomicsTXG | Open-market sale10b5-1 plan | 04/14 | 04/16 | 5,000 sh | $24.56 | $122,800 | −0.4% | |
10x GenomicsTXG | Open-market sale10b5-1 plan | 03/23–03/24 | 03/25 | 15,000 sh2 trades | $19.26avg. | $288,900 | −1.3% | |
10x GenomicsTXG | Open-market sale10b5-1 plan | 03/02 | 03/04 | 16,152 sh2 trades | $22.73avg. | $367,114.44 | −1.3% | |
Sarah A. TeichmannDirector | 10x GenomicsTXG | Open-market sale10b5-1 plan | 02/25 | 02/27 | 7,579 sh | $19.41 | $147,108.39 | −22.1% |
Hindson Benjamin J.SEE REMARKS | 10x GenomicsTXG | Open-market sale | 02/23 | 02/25 | 7,826 sh | $18.58 | $145,407.08 | −1.8% |
10x GenomicsTXG | Open-market sale | 02/23 | 02/25 | 9,632 sh | $18.58 | $178,962.56 | −0.9% | |
Adam TaichCFO | 10x GenomicsTXG | Open-market sale | 02/23 | 02/25 | 8,968 sh | $18.58 | $166,625.44 | −3.0% |
Hindson Benjamin J.SEE REMARKS | 10x GenomicsTXG | Open-market sale | 25/11/24 | 25/11/25 | 8,283 sh | $19.00 | $157,377 | −1.9% |
10x GenomicsTXG | Open-market sale | 25/11/24 | 25/11/25 | 13,261 sh | $19.00 | $251,959 | −1.3% | |
Adam TaichCFO | 10x GenomicsTXG | Open-market sale | 25/11/24 | 25/11/25 | 11,888 sh | $19.00 | $225,872 | −3.8% |
Hindson Benjamin J.SEE REMARKS | 10x GenomicsTXG | Open-market sale | 25/08/22 | 25/08/26 | 7,486 sh | $13.79 | $103,231.94 | −1.7% |
10x GenomicsTXG | Open-market sale | 25/08/22 | 25/08/26 | 9,348 sh | $13.79 | $128,908.92 | −1.0% | |
Adam TaichCFO | 10x GenomicsTXG | Open-market sale | 25/08/22 | 25/08/26 | 22,315 sh | $13.79 | $307,723.85 | −6.7% |